Merck Schering-Plough Reverse Merger Securities Fraud

Schering-Plough Merck Reverse Merger Shareholder Class Action

Schering-Plough and Merck announced plans for a reverse merger to form one company. Under the terms of the reverse merger, Schering-Plough shareholders would be given $10.56 in cash and .5767 shares of Merck stock for each Schering-Plough share. Although these provisions appeared to provide a premium to Schering-Plough stock owners when the deal was announced, many believe that the deal has been grossly unfair to Schering-Plough stockholders. Merck will gain control of the merged companies from the reverse-merger causing Schering-Plough stockholders to object to the proposed reverse merger.

Contact Us

If you own Schering-Plough stock and you object to the Schering-Plough Merck reverse merger, and you would like to speak with an attorney about your rights, contact Seeger Weiss LLP. Our securities fraud team is investigating the Merck Schering-Plough reverse merger for a potential shareholder class action on behalf of Schering-Plough shareholders who feel they have not been offered a reasonable value for their investment. Please use the contact form or call 888-584-0411. Attorney consultations incur no obligation on your part. All initial consultations are free of charge and do not create an attorney-client relationship. Seeger Weiss LLP has office locations in New York, New Jersey, Pennsylvania, Oklahoma, and California and its attorneys are available to practice in courts throughout the country.

Back to list...